Evaluation and management of pericardial effusion in patients with neoplastic disease

Progress in Cardiovascular Diseases

Volumn 53, Issue 2, 2010, Pages 157-163

  Maisch, Bernhard ^a   Ristic, Arsen ^b   Pankuweit, Sabine ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cisplatin; Malignant pericardial effusion; Pericarditis; Radiation induced pericardial effusion; Thiothepa

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CISPLATIN; COLCHICINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE; MITOMYCIN C; OXALIPLATIN; PACLITAXEL; SODIUM CHLORIDE; TAMOXIFEN; TRIAMCINOLONE ACETONIDE; VINBLASTINE; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; COLON CANCER; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DIFFERENTIAL DIAGNOSIS; DRUG MEGADOSE; ESOPHAGUS CANCER; FEMALE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PERICARDIAL BIOPSY; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PROSPECTIVE STUDY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCLEROTHERAPY; SIDE EFFECT; SINGLE DRUG DOSE; VIRUS INFECTION; AGED; BACTERIAL INFECTION; BIOPSY; COMPLICATION; MIDDLE AGED; NEOPLASMS; PATHOLOGY; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; RADIATION INJURIES; RADIOTHERAPY; REGISTER; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; TUMOR INVASION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; RADIATION INJURIES; RADIOTHERAPY; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VIRUS DISEASES;

EID: 77955905030     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2010.06.003     Document Type: Article

References (49)

1. Mukai K., Shinkai T., Tominaga K., et al. The incidence of secondary tumours of the heart and pericardium: a 10 year study. Jpn J Clin Oncol 1988, 18:195-201.
2. Posner M.R., Cohen G.I., Skarin A.T. Pericardial disease in patients with cancer. Am J Med 1981, 71:407-413.
3. Wilding G., Green H.L., Longo D.L., et al. Tumours of the heart and pericardium. Cancer Treat Rev 1988, 15:165-181.
4. Maisch B., Ristic A.D., Seferovic P.M., et al. Interventional pericardiology-pericardiocentesis, pericardioscopy, pericardial biopsy, balloon pericardiotomy and intrapericardial therapy 2010, Springer Heidelberg, Berlin, [With contributions from S Pankuweit, R Maksimovic, H Rupp, JK Oh, JB Seward and AJ Tajik].
5. Maisch B., Seferovic P.M., Ristic A.D., et al. Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines in the diagnosis and management of pericardial diseases. Eur Heart J 2004, 25:587-610.
6. Maisch B., Ristić A.D., Pankuweit S. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone: the way to avoid side effects of systemic corticosteroid therapy. Eur Heart J 2002, 23:1503-1508.
7. Maisch B., Ristić A.D., Pankuweit S., et al. Neoplastic pericardial effusion: efficacy and safety of intrapericardial treatment with cisplatin. Eur Heart J 2002, 23:1625-1631.
8. Spodick D.H. Pericardial diseases. Heart disease 2001, 1823-1876. W.B. Saunders, Philadelphia, PA. 6th ed. E. Braunwald, D.P. Zipes, P. Libby (Eds.).
9. Ziskind A.A., Palacios I.F. Percutaneous balloon pericardiotomy for patients with pericardial effusion and tamponade. Textbook of interventional cardiology 1999, 869-877. W.B. Saunders Co., Philadelphia, PA. 3rd Ed. E.J. Topol (Ed.).
10. Ristić A.D., Seferović P.M., Maksimović R., et al. Percutaneous balloon pericardiotomy in neoplastic pericardial effusion. Pericardiology: contemporary answers to continuing challenges 2000, 427-438. Science, Belgrade. P.M. Seferović, D.H. Spodick, B. Maisch, R. Maksimović, A.D. Ristić (Eds.).
11. Maisch B., Pankuweit S., Brilla C., et al. Intrapericardial treatment of inflammatory and neoplastic pericarditis guided by pericardioscopy and epicardial biopsy-results from a pilot study. Clin Cardiol 1999, 22(Suppl 1):I17-22.
12. Aitini E., Cavazzini G., Pasquini E., et al. Treatment of primary or metastatic pleural effusion with intracavitary cytosine arabinoside and cisplatin. A phase II study. Acta Oncol 1994, 33:191-194.
13. Bindi M., Trusso M., Tucci E. Intracavitary cisplatin in malignant cardiac tamponade. Tumori 1987, 73:163-165.
14. Pavon-Jimenez R., Garcia-Rubira J.C., Garcia-Martinez J.T., et al. Intrapericardial cisplatin for malignant tamponade. Rev Esp Cardiol 2000, 53:587-589.
15. Tomkowski W., Szturmowicz M., Fijalkowska A., et al. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion. J Cancer Res Clin Oncol 1994, 120:434-436.
16. Tomkowski W.Z., Filipecki S. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer. Lung Cancer 1997, 16:215-222.
17. Tomkowski W.Z., Filipecki S. Intrapericardial administration of cisplatin in treatment of metastatic pericardial involvement in adenocarcinoma of the lung. Arch Chest Dis 1997, 52:221-224.
18. Tomkowski W., Szturmowicz M., Fijalkowska A., et al. New approaches to the management and treatment of malignant pericardial effusion. Support Care Cancer 1997, 5:64-66.
19. Fiorentino M.V., Daniele O., Morandi P., et al. Intrapericardial instillation of platin in malignant pericardial effusion. Cancer 1988, 62:1904-1906.
20. Tondini M., Rocco G., Bianchi C., et al. Intracavitary cisplatin (CDDP) in the treatment of metastatic pericardial involvement from breast and lung cancer. Monaldi Arch Chest Dis 1995, 50:86-88.
21. Lestuzzi C.h., Viel E., Sorio R., et al. Local chemotherapy for neoplastic pericardial effusion [letter]. Am J Cardiol 2000, 86:1292.
22. Beretta F., Martinelli G., Cavalli F., et al. Pericardial effusion in patients with malignant neoplasms. Schweiz Med Wochenschr 1992, 122:1517-1524.
23. Bishiniotis T.S., Antoniadou S., Katseas G., et al. Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of triethylenethiophosphoramide (thiotepa). Am J Cardiol 2000, 86:362-364.
24. Colleoni M., Martinelli G., Beretta F., et al. Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen. J Clin Oncol 1998, 16:2371-2376.
25. Girardi L.N., Ginsberg R.J., Burt M.E. Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions. Ann Thorac Surg 1997, 64:1422-1427.
26. Martinoni A., Cipolla C.M., Civelli M., et al. Intrapericardial treatment of neoplastic pericardial effusions. Herz 2000, 25:787-793.
27. Fukuoka M., Takada M., Tamai S., et al. Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion. Gan To Kagaku Ryoho 1984, 11:1543-1549.
28. Lee L.N., Yang P.C., Chang D.B., et al. Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion. Thorax 1994, 49:594-595.
29. Liu G., Crump M., Goss P.E., et al. Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade. J Clin Oncol 1996, 14:3141-3147.
30. van der Gaast A., Kok T.C., van der Linden N.H., et al. Intrapericardial instillation of bleomycin in the management of malignant pericardial effusion. Eur J Cancer Clin Oncol 1989, 25:1505-1506.
31. Yano T., Yokoyama H., Inoue T., et al. A simple technique to manage malignant pericardial effusion with a local instillation of bleomycin in non-small cell carcinoma of the lung. Oncology 1994, 51:507-509.
32. Cormican M.C., Nyman C.R. Intrapericardial bleomycin for the management of cardiac tamponade secondary to malignant pericardial effusion. Br Heart J 1990, 63:61-62.
33. Davis S., Rambotti P., Grignani F. Intrapericardial tetracycline sclerosis in the treatment of malignant pericardial effusion: an analysis of thirty-three cases. J Clin Oncol 1984, 2:631-636.
34. Maher E.A., Shepherd F.A., Todd T.J. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg 1996, 112:637-643.
35. Salamon P., Berliner S., Shachner A., et al. Tetracycline treatment for malignant pericardial effusion. Med Interne 1989, 27:73-74.
36. Shepherd F.A., Ginsberg J.S., Evans W.K., et al. Tetracycline sclerosis in the management of malignant pericardial effusion. J Clin Oncol 1985, 3:1678-1682.
37. Shepherd F.A., Morgan C., Evans W.K., et al. Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol 1987, 60:1161-1166.
38. Norum J., Lunde P., Aasebo U., et al. Mitoxantrone in malignant pericardial effusion. J Chemother 1998, 10:399-404.
39. Primrose W.R., Clee M.D., Johnston R.N. Malignant pericardial effusion managed with Vinblastine. Clin Oncol 1983, 9:67-70.
40. Dempke W., Firusian N. Treatment of malignant pericardial effusion with 32P-colloid. Br J Cancer 1999, 80:1955-1957.
41. Firusian N. 32P therapy of malignant pericardial effusions. Onkologie 1980, 3:12-17.
42. Martini N., Freiman A.H., Watson R.C., et al. Intrapericardial installation of radioactive chromic phosphate in malignant effusion. AJR Am J Roentgenol 1977, 128:639-641.
43. Sprengelmeyer J.T., McDermott R.L. Phosphorus-32-colloidal chromic phosphate: treatment of choice for malignant pericardial effusion. J Nucl Med 1990, 31:2034-2036.
44. Lissoni P., Barni S., Tancini G., et al. Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2. Support Care Cancer 1995, 3:78-80.
45. Imamura T., Tamura K., Takenaga M., et al. Intrapericardial OK-432 instillation for the management of malignant pericardial effusion. Cancer 1991, 68:259-263.
46. Keane D., Jackson G. Managing recurrent malignant pericardial effusions. Br Med J 1992, 305:729-730.
47. Tulleken J.E., Kooiman C.G., van der Werf T.S., et al. Constrictive pericarditis after high-dose chemotherapy. Lancet 1997, 350:1601.
48. Kahles H., Bastian H.J., Schiffmann O., et al. Mitoxantrone-induced acute left heart failure after intrapleural administration. Herz 1997, 22:217-220.
49. Seferović P.M., Ristić A.D., Maksimović R., et al. Treatment of neoplastic pericardial effusion: percutaneous balloon pericardiotomy vs. prolonged subxiphoid drainage [abstract]. Eur Heart J 2000, 21(Suppl. August/September):418.